Recently, several oral anti-cancer drugs have been approved and there are many... The development of an oral anti-cancer drug is likely to require more. Oral Cancer Drug REVLIMID(R) Receives Positive Opinion for Treatment of Multiple Myeloma From European Medicines NEUCHATEL,. Oral Cancer Drug REVLIMID Receives Swissmedic Approval in Switzerland for Treatment of Multiple Myeloma from Business Wire in Business provided free by. Cancer of the Tongue, a malignant IP&L tumor that begins as a small lump,. New Targeted Approach To Light-Activated Cancer Drugs With Tumor-Seeking

Drug Shows Promise in Laboratory as Oral Cancer Treatment. November 14, 2006 For the thousands of Americans diagnosed each year with oral squamous cell. Medicare Plan Could Make Oral Cancer

Drugs a Tough Swallow. By Paul Multiple Myeloma J.